The Clinical Researh about Different Anti-Virus Treatment Based on Gancyclovir for Preventing Cytomegaloirus Disease After Renal Transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-PRC-08000237

Enrollment

Unknown

Registered

2008-12-16

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegaloirus Disease After Renal Transplantation

Interventions

A:none

B:none

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ?

Exclusion criteria

Exclusion criteria: ?

Design outcomes

Primary

Measure	Time frame
SEN, SPE;	—

Secondary

Measure	Time frame
Infection rate;	—

Countries

China

Contacts

Public ContactLizhong Chen

clz@medmail.com.cn+86 0 13902303569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026